Biotechnologies Available for Licensing:
By Title

Available biotechnologies may also be viewed by type and application, or downloaded here.

in vivo data availablein vivo data available

 

Title Tech ID #
SERCA2: Novel Target for the Treatment of Cystic Fibrosis 09-05
Adenosine A2A Receptor:  A Prognosis Marker for Lung Cancer 08-11
Novel TLR Inhibitors Prevent Respiratory Syncytial Virus Infection In Vivo  in vivo data available 07-07
Treatment with an Antibody Against VGamma4 T Cells Reduces Rheumatoid Arthritis Symptoms in Micein vivo data available 07-06
Knee aspirate facilitator 07-02
MAGP-2: An extracellular factor shown to have pro-angiogenic properties in vivo in vivo data available 06-05
Method to prevent biofilm formation in various clinical settings (contact lenses, wounds, cystic fibrosis, etc.)  04-08
Cystatin C: an extracellular antagonist of the TGF beta receptor. Potential therapies for cancer and fibrotic diseases 04-05
Method for identifying MHC-presented epitopes for T cells 03-01
Modulating the transport of thiol-containing molecules for the treatment of lung disease and cancerin vivo data available 02-16
Efficient method to produce mature neutrophils from embryonic stem cells 02-08
Liposomal clodronate as a therapy for autoimmune hemolytic anemiain vivo data available 02-07
High-throughput cell based assay for the identification of drugs targeting the NF-kB signaling pathway 02-05
Use of aerosolized anti-TCR monoclonal antibodies as a therapy for airway hyperresponsivenessin vivo data available 01-01
Calcitonin Gene-Related Peptide For The Reduction Of Allergen-Induced Airway Hyperresponsivenessin vivo data available 00-14
Cdk6 as a marker for breast cancer 00-11
New Agar Medium for the Isolation and Testing Susceptibility of Mycobacterium Tuberculosis Against Drugs 00-05
Novel molecular targets for anti-inflammatory drug development:
- TALL-1: A member of the TNF gene family
- TALL-1 receptor (BCMA)
- TALL-1 and receptors 3D structure
00-01
Method for treating inflammatory diseases using heat shock proteinsin vivo data available 98-07
Anti-CD79 antibody offers novel approach to therapy in autoimmune disease, transplantation and lymphomain vivo data available 98-04
Thioredoxins for the treatment of lung diseasein vivo data available 96-07
Method to Identify Compounds Regulating Actin Polymerization  96-06
Peptides offer strategies for novel immunosuppressants and anti-herpes agents 96-02
Promising gene immunotherapy technology fights tumors and infectious diseasesin vivo data available 95-03
Method to Produce Monoclonal Antibodies to Human T-Cell Receptor Elements 91-02

 

Research Tools

View list of available Antibodies or Animal models.

 

Biomedical Devices

View list of available biomedical devices.

 

For more information, contact Emmanuel Hilaire at [email protected].

 


1-800-222-5864
Refer a Patient

Connect with Us Online


Become our fan on facebook!   Subscribe to our YouTube channel!   Follow us on Twitter!   Subscribe to our News RSS feed.  Learn about CarePages, an online support community.

eNewsletters and More

Faculty by Research


The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our A-Z directory of Faculty by Area of Research.